Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness

References

• Unemo M, Lahra MM, Cole M, et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health. 2019 Sep;16(5):412–425. doi: 10.1071/SH19023
   PubMed Web of Science ®Google Scholar
• Edwards JL, Apicella MA. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev. 2004 Oct;17(4):965–981. doi: 10.1128/CMR.17.4.965-981.2004
   PubMed Web of Science ®Google Scholar
• Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med. 2003 Apr;36(4):502–509. doi: 10.1016/S0091-7435(02)00058-0
   PubMed Web of Science ®Google Scholar
• Hook EW, Bernstein K. Kissing, saliva exchange, and transmission of Neisseria gonorrhoeae. Lancet Infect Dis. 2019 Oct;19(10):e367–e369. doi: 10.1016/S1473-3099(19)30306-8
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014 Jul;27(3):587–613. doi: 10.1128/CMR.00010-14
   PubMed Web of Science ®Google Scholar
• Fifer H, Cole M, Hughes G, et al. Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study. Lancet Infect Dis. 2018 May;18(5):573–581. doi: 10.1016/S1473-3099(18)30122-1
   PubMed Web of Science ®Google Scholar
• Katz AR, Komeya AY, Kirkcaldy RD, et al. Cluster of Neisseria gonorrhoeae isolates with high-level azithromycin resistance and decreased ceftriaxone susceptibility, Hawaii, 2016. Clin Infect Dis. 2017 Sep 15;65(6):918–923. doi: 10.1093/cid/cix485
   PubMed Web of Science ®Google Scholar
• Yan J, Xue J, Chen Y, et al. Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17). J Antimicrob Chemother. 2019 Oct 16;74(1):29–37.
   PubMed Web of Science ®Google Scholar
• Kong FYS, Horner P, Unemo M, et al. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J Antimicrob Chemother. 2019 May 1;74(5):1157–1166. doi: 10.1093/jac/dky548
   PubMed Web of Science ®Google Scholar
• Ison CA, Town K, Obi C, et al. Decreased susceptibility to cephalosporins among gonococci: data from the gonococcal resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. Lancet Infect Dis. 2013 Sep;13(9):762–768. doi: 10.1016/S1473-3099(13)70143-9
   PubMed Web of Science ®Google Scholar
• Shimuta K, Watanabe Y, Nakayama S, et al. Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan. BMC Infect Dis. 2015 Sep 17;15:378. doi: 10.1186/s12879-015-1110-x
   PubMed Web of Science ®Google Scholar
• Yin YP, Han Y, Dai XQ, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018 Feb;15(2):e1002499. doi: 10.1371/journal.pmed.1002499
   PubMed Web of Science ®Google Scholar
• Chen MY, Stevens K, Tideman R, et al. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother. 2013 Jun;68(6):1445–1447. doi: 10.1093/jac/dkt017
   PubMed Web of Science ®Google Scholar
• Poncin T, Fouere S, Braille A, et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Euro Surveill. 2018 May;23(21):1800264. doi: 10.2807/1560-7917.ES.2018.23.21.1800264
   PubMedGoogle Scholar
• Tapsall J, Read P, Carmody C, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009 May;58(Pt 5):683–687. doi: 10.1099/jmm.0.007641-0
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011 Feb 10;16(6):19792.
   PubMedGoogle Scholar
• Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012 Mar;56(3):1273–1280. doi: 10.1128/AAC.05760-11
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Potocnik M, et al. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 2012 Jun 21;17(25):20200.
   PubMedGoogle Scholar
• Camara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012 Aug;67(8):1858–1860. doi: 10.1093/jac/dks162
   PubMed Web of Science ®Google Scholar
• Deguchi T, Yasuda M, Hatazaki K, et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg Infect Dis. 2016 Jan;22(1):142–144. doi: 10.3201/eid2201.150868
   PubMed Web of Science ®Google Scholar
• Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med. 2014 Nov 6;371(19):1850–1851. doi: 10.1056/NEJMc1408109
   PubMed Web of Science ®Google Scholar
• Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011 Jul;55(7):3538–3545. doi: 10.1128/AAC.00325-11
   PubMed Web of Science ®Google Scholar
• Nakayama S, Shimuta K, Furubayashi K, et al. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016 Jul;60(7):4339–4341. doi: 10.1128/AAC.00504-16
   PubMed Web of Science ®Google Scholar
• Lee K, Nakayama SI, Osawa K, et al. Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. J Antimicrob Chemother. 2019 Jul 1;74(7):1812–1819. doi: 10.1093/jac/dkz129
   PubMed Web of Science ®Google Scholar
• Chen SC, Han Y, Yuan LF, et al. Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019 Jul;25(7):1427–1429. doi: 10.3201/eid2507.190172
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang H, Chen Y, et al. Detection and analysis of two cases of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother. 2019 Dec 1;74(12):3635–3636. doi: 10.1093/jac/dkz384
   PubMed Web of Science ®Google Scholar
• Yuan Q, Li Y, Xiu L, et al. Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018. Emerg Microbes Infect. 2019;8(1):1546–1549. doi: 10.1080/22221751.2019.1681242
   PubMed Web of Science ®Google Scholar
• Terkelsen D, Tolstrup J, Johnsen CH, et al. Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill. 2017 Oct;22(42):1700659. doi: 10.2807/1560-7917.ES.2017.22.42.17-00659
   Google Scholar
• Lefebvre B, Martin I, Demczuk W, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Canada, 2017. Emerg Infect Dis. 2018 Feb;24(2):381–383. doi: 10.3201/eid2402.171756
   PubMed Web of Science ®Google Scholar
• Lahra MM, Martin I, Demczuk W, et al. Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis. 2018 Apr;24(4):735–740. doi: 10.3201/eid2404.171873
   PubMed Web of Science ®Google Scholar
• Golparian D, Rose L, Lynam A, et al. Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill. 2018 Nov;23(47):1800617. doi: 10.2807/1560-7917.ES.2018.23.47.1800617
   PubMedGoogle Scholar
• Eyre DW, Town K, Street T, et al. Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018. Euro Surveill. 2019 Mar;24(10):1900147. doi: 10.2807/1560-7917.ES.2019.24.10.1900147
   PubMedGoogle Scholar
• Eyre DW, Sanderson ND, Lord E, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018 Jul;23(27):1800323. doi: 10.2807/1560-7917.ES.2018.23.27.1800323
   PubMedGoogle Scholar
• Chen SC, van der Veen S, Yin YP. Widespread transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. Submitted.
   Google Scholar
• Yan J, Chen Y, Yang F, et al. High incidence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in Hangzhou, China. Submitted.
   Google Scholar
• Tomberg J, Unemo M, Ohnishi M, et al. Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041. Antimicrob Agents Chemother. 2013 Jul;57(7):3029–3036. doi: 10.1128/AAC.00093-13
   PubMed Web of Science ®Google Scholar
• Singh A, Tomberg J, Nicholas RA, et al. Recognition of the beta-lactam carboxylate triggers acylation of Neisseria gonorrhoeae penicillin-binding protein 2. J Biol Chem. 2019 Sep 20;294(38):14020–14032. doi: 10.1074/jbc.RA119.009942
   PubMed Web of Science ®Google Scholar
• Tomberg J, Unemo M, Davies C, et al. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry. 2010 Sep 21;49(37):8062–8070. doi: 10.1021/bi101167x
   PubMed Web of Science ®Google Scholar
• Vincent LR, Kerr SR, Tan Y, et al. In vivo-selected compensatory mutations restore the fitness cost of mosaic penA alleles that confer ceftriaxone resistance in Neisseria gonorrhoeae. MBio. 2018 Apr 3;9(2):e01905-17. doi: 10.1128/mBio.01905-17
   PubMed Web of Science ®Google Scholar
• Zhang J, van der Veen S. Neisseria gonorrhoeae 23S rRNA A2059G mutation is the only determinant necessary for high-level azithromycin resistance and improves in vivo biological fitness. J Antimicrob Chemother. 2019 Feb 1;74(2):407–415. doi: 10.1093/jac/dky438
   PubMed Web of Science ®Google Scholar
• Wang S, Xue J, Lu P, et al. Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies. J Infect. 2018 Sep;77(3):191–204. doi: 10.1016/j.jinf.2018.06.001
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang X, Lu P, et al. Identification and characterization of the Neisseria gonorrhoeae MscS-like mechanosensitive channel. Infect Immun. 2018 Jun;86(6):e00090-18. doi: 10.1128/IAI.00090-18
   PubMed Web of Science ®Google Scholar
• Jerse AE, Sharma ND, Simms AN, et al. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect Immun. 2003 Oct;71(10):5576–5582. doi: 10.1128/IAI.71.10.5576-5582.2003
   PubMed Web of Science ®Google Scholar
• Ito M, Deguchi T, Mizutani KS, et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother. 2005 Jan;49(1):137–143. doi: 10.1128/AAC.49.1.137-143.2005
   PubMed Web of Science ®Google Scholar
• Lee H, Suh YH, Lee S, et al. Emergence and spread of cephalosporin-resistant Neisseria gonorrhoeae with mosaic penA alleles, South Korea, 2012-2017. Emerg Infect Dis. 2019 Mar;25(3):416–424. doi: 10.3201/eid2503.181503
   PubMed Web of Science ®Google Scholar
• Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol. 1999 Oct;2(5):489–493. doi: 10.1016/S1369-5274(99)00005-3
   PubMed Web of Science ®Google Scholar
• Nilsson AI, Zorzet A, Kanth A, et al. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc Natl Acad Sci U S A. 2006 May 2;103(18):6976–6981. doi: 10.1073/pnas.0602171103
   PubMed Web of Science ®Google Scholar
• Tomberg J, Fedarovich A, Vincent LR, et al. Alanine 501 mutations in penicillin-binding protein 2 from Neisseria gonorrhoeae: structure, mechanism, and effects on cephalosporin resistance and biological fitness. Biochemistry. 2017 Feb 28;56(8):1140–1150. doi: 10.1021/acs.biochem.6b01030
   PubMed Web of Science ®Google Scholar
• Warner DM, Folster JP, Shafer WM, et al. Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J Infect Dis. 2007 Dec 15;196(12):1804–1812. doi: 10.1086/522964
   PubMed Web of Science ®Google Scholar
• Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol. 2008 Oct;70(2):462–478. doi: 10.1111/j.1365-2958.2008.06424.x
   PubMed Web of Science ®Google Scholar